NCT03503929

Brief Summary

LaparoGuard is intended as an adjunctive safety system for laparoscopic surgery. The system allows surgeons to virtually annotate a safe anatomical volume inside the body cavity of the patient during a laparoscopic surgery. The surgeon then receives notification throughout the procedure whenever a tracked rigid instrument has exited that volume. This open label, prospective, feasibility, single site, multi-investigator trial will evaluate the feasibility and usability of the LaparoGuard system during laparoscopic surgical procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 20, 2018

Completed
1.2 years until next milestone

Study Start

First participant enrolled

June 21, 2019

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
Last Updated

March 15, 2023

Status Verified

March 1, 2023

Enrollment Period

5.3 years

First QC Date

January 25, 2018

Last Update Submit

March 13, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Procedural Success

    For each surgical procedure conducted, the case will be defined as a technical success if: the surgical team is able to complete the procedure without needing to turn off the LaparoGuard system. Failure will be if the operator deems it necessary to stop utilizing the LaparoGuard system and resort to the standard (non-annotated) endoscopic camera feed. Potential reasons for doing so may be device reporting errors, such as the LaparoGuard system consistently incorrectly reporting that a surgical tool has exited the safe zone. In emergency situations, such as changes in medical condition unrelated to use of the LaparoGuard system, the operator may also deem it necessary to resort to the standard-of-care; however, these situations will not be judged as failures and the case data will be utilized for study purposes up until that point.

    Intraoperative

Secondary Outcomes (6)

  • Pre-operative LaparoGuard system setup time

    Baseline

  • Usability reported pre-operatively by nurses

    Baseline

  • Safe zone deviations

    Intraoperative

  • Usability reported post-operatively by surgical team

    Intraoperative

  • Clinical utility reported by expert surgeons

    2 months

  • +1 more secondary outcomes

Study Arms (1)

LaparoGuard System

OTHER

All patients receiving laparoscopic surgery, candidates for prolonged time under anesthesia, and are admitted for gynecological, urological or general surgery procedures who consent to use of the LaparoGuard System.

Device: LaparoGuard System

Interventions

Adjunctive safety system for laparoscopic surgery

LaparoGuard System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing routine laparoscopic procedures. Examples include (non-exhaustive): operative laparoscopy, appendectomy, cholecystectomy, colon resection, inguinal or diaphragmatic hernia repairs.
  • Ability to read and understand English
  • Consent to use of the LaparoGuard system in their procedure (18 yrs or older)

You may not qualify if:

  • Unwilling to sign informed consent
  • Simple diagnostic laparoscopy (can be included if conversion to operative laparoscopy)
  • Surgeries which require conversion to laparotomy for patient safety reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hamilton General Hospital

Hamilton, Ontario, L8L 2X2, Canada

Location

Study Officials

  • Niv Sne, MD

    Hamilton Health Sciences Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: Open label, prospective, single site, multi-investigator
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2018

First Posted

April 20, 2018

Study Start

June 21, 2019

Primary Completion

September 30, 2024

Study Completion

October 30, 2024

Last Updated

March 15, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations